Zantac
In October 2019, a class-action lawsuit was filed against Sanofi for allegedly misleadingly marketing the over-the-counter heartburn medication Zantac as safe when, according to plaintiffs, the medicine contains dangerously high levels of the carcinogen N-nitrosodimethylamine (NDMA). (Rodriguez et al v. Sanofi U.S. LLC et al, Case No. 19-cv-9527, S. D. NY.)
Class-Action Tracker
The Latest
Lean Cuisine Salisbury Steak
Beef isn’t the only meat on the menu.
Roblox ads enticed, targeted kids as young as 5 to try caffeinated potato chips, watchdog says
Lisa Fickenscher, The New York Post
Roblox Still Exposing Minors to Deceptive, Harmful Ads
It’s gotten worse.
Brigit Cash Advance App
How fast cash claims can fast track your money problems.
Earth Breeze Laundry Detergent Sheets
TINA.org wades into the marketing of these “eco sheets.”